# Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

> **NCT04680832** · — · ACTIVE_NOT_RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 600 (estimated)

## Conditions studied

- Pulmonary Fibrosis

## Interventions

- **DIAGNOSTIC_TEST:** Electronic nose

## Key facts

- **NCT ID:** NCT04680832
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04680832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04680832, "Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04680832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*